Company / Gross Profit
Insight Molecular Diagnostics Inc. Gross Profit History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$740.0K
FY2025
5-year range
-$639.0K / $1.4M
FY2021-FY2025
Trend
+79.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$18,000 to $740,000 over the past 2 years.
Based on SEC 10-K filings.
$740,000 in FY2025 with a 3-year CAGR of -19.5%.
Improved from -$18,000 to $740,000 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -19.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -19.5%, indicating a declining trend.
- In FY2025, gross profit increased 79.2% year-over-year.
- Peak gross profit was recorded in FY2022.
- Lowest gross profit in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $740.0K | +79.2% |
| FY2024 | $413.0K | +2394.4% |
| FY2023 | -$18.0K | -101.3% |
| FY2022 | $1.4M | +322.2% |
| FY2021 | -$639.0K | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026